Moderna Allocates $3 Million to Progress mRNA Therapeutics in Australia

Australia's Monash University and American firm Moderna have announced the establishment of the Monash-Moderna Quantitative Pharmacology Accelerator (MMQPA...

August 18, 2023 | Friday | News
Propanc Targets First Human Study Site at Peter Mac Cancer Center, Australia

The Peter Mac Cancer Center is a world leading cancer research, education and treatment center and Australia’s only public health service dedicated t...

August 16, 2023 | Wednesday | News
Sun Pharma and Philogen Partner for Exclusive Distribution, License, and Supply of NIDLEGY™ in Europe, Australia, and New Zealand

Under the terms of the agreement, Sun Pharma will have exclusive rights to commercialise Nidlegy™ for indications of skin cancers in the territories ...

May 30, 2023 | Tuesday | News
Junshi Biosciences and Dr. Reddy's Partner to Develop Toripalimab in 21 Countries.

“We are thrilled to have established a partnership with Dr. Reddy’s while toripalimab’s global commercial network has been steadily expan...

May 08, 2023 | Monday | News
Orion Health bolsters North American operations with tech and leadership.

Orion Health, a global leader in population health software, is strengthening its position in North America with new technology and the appointment of Jame...

March 26, 2023 | Sunday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close